Case: 24-1011 Document: 55 Page: 1 Filed: 05/19/2025

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ MYLAN PHARMACEUTICALS INC., Appellant v. BAUSCH HEALTH IRELAND LTD., Appellee ______________________ 2024-1011 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2022- 00722, IPR2023-00016.

-------------------------------------------------- MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., Appellants v. BAUSCH HEALTH IRELAND LTD., Appellee ______________________ 2024-1053 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2022- 00722, IPR2023-00016.

Case: 24-1011 Document: 55 Page: 2 Filed: 05/19/2025

2 MYLAN PHARMACEUTICALS INC. v. BAUSCH HEALTH IRELAND LTD.

______________________ ON STIPULATION ______________________ PER CURIAM.

ORDER Mylan Pharmaceuticals Inc. and Bausch Health Ire- land Ltd stipulate to voluntary dismissal of Appeal No. 24- 1011.

The parties, having so agreed, IT IS ORDERED THAT: (1) Appeal No. 24-1011 is dismissed under Fed. R. App. P. 42(b), with each side to bear their own costs. (2) The official captions as modified, are reflected in this order.

FOR THE COURT

May 19, 2025 Date

ISSUED AS A MANDATE (as to Appeal No. 24-1011 only): May 19, 2025.